What is prenatal screening and why to do it?

Seminars in Perinatology

Volumn 40, Issue 1, 2016, Pages 3-11

  Temming, Lorene A ^a   Macones, George A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Aneuploidy screening; Genetic screening; Prenatal screening

Indexed keywords

ANEUPLOIDY; CONGENITAL MALFORMATION; DOWN SYNDROME; FALSE POSITIVE RESULT; FETUS ECHOGRAPHY; GAUCHER DISEASE; GENETIC SCREENING; HUMAN; MASS SCREENING; MENINGOMYELOCELE; MONOSOMY X; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TAY SACHS DISEASE; TRISOMY 21; TURNER SYNDROME; AMNIOCENTESIS; BLOOD; CHORION VILLUS SAMPLING; CHROMOSOME DISORDERS; CONGENITAL ABNORMALITIES; FEMALE; FETUS; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

DNA;

AMNIOCENTESIS; ANEUPLOIDY; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; CONGENITAL ABNORMALITIES; DNA; FEMALE; FETUS; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 84959113973     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.11.002     Document Type: Review

References (52)

1. Raffe A.E., Gray J.A. "How Screening Started." From Screening: Evidence and Practice 2009, Oxford: Oxford University Press, pp.1-29.
2. Gates T.J. Screening for cancer: evaluating the evidence. Am Fam Physician 2001, 63(3):513-522.
3. Gorroll A.H., May L.A., Mulley A.G. "Health Maintenance and the Role of Screening" From Primary Care Medicine: Office Evaluation and Management of the Adult Patient 2009, Boston: Lippincott Williams & Wilkins Health. 7th ed.
4. Cuckle H.S., Wald N. "Tests Using Single Markers" From Antenatal and Neonatal Screening 2000, Oxford: Oxford University Press, pp.1-22.
5. Manning Frank A. "Imaging in the Diagnosis of Fetal Anomalies." From Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice 2009, Philadelphia: Elsevier/Saunders, 275-304. 6th ed.
6. Egbe A., Lee S., Ho D., Uppu S., Srivastava S. Racial/ethnic differences in the birth prevalence of congenital anomalies in the United States. J Perinat Med 2015, 43(1):111-117. 10.1515/jpm-2013-0344.
7. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2011, National Cancer Institute;Bethesda, MD, [based on November 2013 SEER data submission, posted to the SEER web site, April] 2014. http://seer.cancer.gov/csr/1975_2011/.
8. Moldenhauer J.S. In utero repair of spina bifida. Am J Perinatol 2014, 31(7):595-604. [2014 May 12]. 10.1055/s-0034-1372429.
9. Shaer C.M., Chescheir N., Schulkin J. Myelomeningocele: a review of the epidemiology, genetics, risk factors for conception, prenatal diagnosis, and prognosis for affected individuals. Obstet Gynecol Surv 2007, 62(7):471-479.
10. American College of Obstetricians and Gynecologists ACOG Committee opinion no. 550: maternal-fetal surgery for myelomeningocele. Obstet Gynecol 2013, 121(1):218-219.
11. Adzick N.S., Thom E.A., Spong C.Y., et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011, 364(11):993-1004.
12. Callen Peter W. Ultrasonography in Obstetrics and Gynecology 2008, Saunders Elsevier, Philadelphia, PA. 5th ed.
13. Wald N. "Down's Syndrome" from Antenatal and Neonatal Screening 2000, Oxford University Press, Oxford.
14. Presson A.P., Partyka G., Jensen K.M., et al. Current estimate of Down syndrome population prevalence in the United States. J Pediatr 2013, 163(4):1163-1168.
15. Song K., Musci T.J., Caughey A.B. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern Fetal Neonatal Med 2013, 26(12):1180-1185.
16. Macones G.A., Odibo A. First trimester screening: economic implications. Semin Perinatol 2005, 29(4):263-266. [Review].
17. National Down's Syndrome Society. "A Promising Future Together." . http://www.ndss.org.
18. Hixson L., Goel S., Schuber P., et al. An overview on prenatal screening for chromosomal aberrations. J Lab Autom 2015.
19. Edwards J.G., Feldman G., Goldberg J., et al. Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the american college of medical genetics and genomics, american college of obstetricians and gynecologists, national society of genetic counselors, perinatal quality foundation, and society for maternal-fetal medicine. Obstet Gynecol 2015, 125(3):653-662.
20. ACOG committee on genetics ACOG Committee opinion no. 442: preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2009, 114(4):950-953.
21. Wang R.Y., Bodamer O.A., Watson M.S., Wilcox W.R., ACMG work group on diagnostic confirmation of lysosomal storage diseases Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 2011, 13(5):457-484.
22. Reddy U.M., Abuhamad A.Z., Levine D., Saade G.R., Fetal imaging workshop invited participants Fetal imaging: executive summary of a joint eunice kennedy shriver national institute of child health and human development, society for maternal-fetal medicine, american institute of ultrasound in medicine, american college of obstetricians and gynecologists, american college of radiology, society for pediatric radiology, and society of radiologists in ultrasound fetal imaging workshop. Am J Obstet Gynecol 2014, 210(5):387-397.
23. Yagel S., Cohen S.M., Porat S., et al. Detailed transabdominal fetal anatomic scanning in the late first trimester versus the early second trimester of pregnancy. J Ultrasound Med 2015, 34(1):143-149.
24. Clementi M., Tenconi R., Bianchi F., Stoll C. Evaluation of prenatal diagnosis of cleft lip with or without cleft palate and cleft palate by ultrasound: experience from 20 European registries. EUROSCAN study group. Prenat Diagn 2000, 20(11):870-875.
25. Stoll C., Wiesel A., Queisser-Luft A., Froster U., Bianca S., Clementi M. Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn 2000, 20(10):811-818.
26. Dicke J.M., Piper S.L., Goldfarb C.A. The utility of ultrasound for the detection of fetal limb abnormalities-a 20-year single-center experience. Prenat Diagn 2014.
27. Boyd P.A., Rounding C., Chamberlain P., Wellesley D., Kurinczuk J.J. The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period. Br J Obstet Gynecol 2012, 119(9):1131-1140.
28. LeFevre M.L., Bain R.P., Ewigman B.G., Frigoletto F.D., Crane J.P., McNellis D. A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group. Am J Obstet Gynecol 1993, 169(3):483-489.
29. Leivo T., Tuominen R., Saari-Kemppainen A., Ylöstalo P., Karjalainen O., Heinonen O.P. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol 1996, 7(5):309-314.
30. Whitworth M., Bricker L., Neilson J.P., Dowswell T. Ultrasound for fetal assessment in early pregnancy. Cochrane Database 2010, 14(4):CD007058.
31. Wapner R. "Prenatal Diagnosis of Congenital Disorders." From Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice 2013, 417-464. Philadelphia: Elsevier/Saunders. 7th ed.
32. American College of Obstetricians and Gynecologists Committee on Genetics Committee opinion no. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012, 120(6):1532-1534.
33. Norton M.E., Rose N.C., Benn P. Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstet Gynecol 2013, 121(4):847-850.
34. Benn P., Borell A., Chiu R., et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for prenatal diagnosis. Prenat Diagn 2013, 33(7):622-629.
35. Norton M.E., Jacobsson B., Swamy G.K., et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015, 372(17):1589-1597.
36. Cuckle H., Benn P., Pergament E. Maternal cfDNA screening for Down syndrome-a cost sensitivity analysis. Prenat Diagn 2013, 33(7):636-642.
37. Song K., Musci T.J., Caughey A.B. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern Fetal Neonatal Med 2013, 26(12):1180-1185.
38. American Institute of Ultrasound in Medicine AIUM Practice guideline for the performance of an antepartum obstetric ultrasound examination. J Ultrasound Med 2003, 22(10):1116-1125.
39. ACOG Committee on Practice Bulletins ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109(1):217-227.
40. Tang H., Quertermous T., Rodriguez B., et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005, 76(2):268-275.
41. Dumitrescu L., Ritchie M.D., Brown-Gentry K., et al. Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records. Genet Med 2010, 12(10):648-650.
42. Lu M.C., Halfon N. Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J 2003, 7(1):13-30. [Review. PubMed PMID: 12710797].
43. State Medicaid Coverage of Perinatal Services: A Summary of Findings. https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8014.pdf.
44. Kozhimannil K.B., Abraham J.M., Virnig B.A. National trends in health insurance coverage of pregnant and reproductive-age women, 2000 to 2009. Womens Health Issues 2012, 22(2):e135-e141.
45. Sutherland S., Farrell R.M., Lockwood C. Genetic screening and testing in an episode-based payment model: preserving patient autonomy. Obstet Gynecol 2014, 124(5):987-991.
46. Manegold-Brauer G., Berg C., Flöck A., Rüland A., Gembruch U., Geipel A. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in atertiary referral center. Arch Gynecol Obstet 2015.
47. Friel L.A., Czerwinski J.L., Singletary C.N. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine. Am J Perinatol 2014, 31(9):759-764. 10.1055/s-0033-1359717.
48. Rossi A.C., Prefumo F. Accuracy of ultrasonography at 11-14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol 2013, 122(6):1160-1167.
49. Spaggiari E., Ruas M., Dreux S., et al. Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay. Am J Obstet Gynecol 2013, 208(4):303.e1-303.e7.
50. Pinto N.M., Nelson R., Puchalski M., Metz T.D., Smith K.J. Cost-effectiveness of prenatal screening strategies for congenital heart disease. Ultrasound Obstet Gynecol 2014, 44(1):50-57.
51. Department of Agriculture Food and nutrition service national school lunch, special milk, and school breakfast programs, national average payments/maximum reimbursement rates. Federal Register 2011, 76. [No. 139. Wednesday, July 20].
52. Chervenak F.A., McCullough L.B. Ethical dimensions of first-trimester fetal aneuploidy screening. Clin Obstet Gynecol 2014, 57(1):226-231.